Copyright
©The Author(s) 2022.
World J Clin Cases. Jan 7, 2022; 10(1): 217-226
Published online Jan 7, 2022. doi: 10.12998/wjcc.v10.i1.217
Published online Jan 7, 2022. doi: 10.12998/wjcc.v10.i1.217
Measure | Value1 |
Age (yr) | 60 (35-74) |
Sex | |
Male | 16 (66.7) |
Female | 8 (33.3) |
Symptoms2,3 | |
Abdominal pain | 17 (70.8) |
Nausea and vomiting | 12 (50.0) |
Abdominal distention | 9 (37.5) |
Constipation | 5 (20.8) |
Diarrhea (bloody or non-bloody) | 3 (12.5) |
Hematemesis | 1 (4.2) |
Signs2,3 | |
Ascites | 7 (29.2) |
Abdominal tenderness | 6 (25.0) |
Fever | 3 (12.5) |
Hypotension (SBP < 90) | 1 (4.2) |
Jaundice | 1 (4.2) |
Risk factors2,3 | |
Liver cirrhosis | 11 (45.8) |
Intra-abdominal surgery | 11 (45.8) |
Pancreatic cancer | 6 (25.0) |
Intra-abdominal infection | 4 (16.7) |
Hepatocellular carcinoma | 3 (12.5) |
Others | 9 (37.5) |
- Citation: Alnahhal K, Toskich BB, Nussbaum S, Li Z, Erben Y, Hakaim AG, Farres H. Superior mesenteric venous thrombosis: Endovascular management and outcomes. World J Clin Cases 2022; 10(1): 217-226
- URL: https://www.wjgnet.com/2307-8960/full/v10/i1/217.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i1.217